Malignant Genitourinary System Neoplasm — Research

Malignant Genitourinary System Neoplasm — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed14 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-28	758	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab])`	2026-09-28	pubmed
Last 5 years	2021-01-01 → 2026-12-31	334	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-28	pubmed
Preceding 5-year window	2020-09-28 → 2025-09-27	302	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2020/09/28:2025/09/27[dp])`	2026-09-28	pubmed
Last 12 months	2025-09-28 → 2026-09-28	65	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2025/09/28:2026/09/28[dp])`	2026-09-28	pubmed
y2016	2016-01-01 → 2016-12-31	24	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2016/01/01:2016/12/31[dp])`	2026-09-28	pubmed
y2017	2017-01-01 → 2017-12-31	34	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2017/01/01:2017/12/31[dp])`	2026-09-28	pubmed
y2018	2018-01-01 → 2018-12-31	28	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2018/01/01:2018/12/31[dp])`	2026-09-28	pubmed
y2019	2019-01-01 → 2019-12-31	45	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2019/01/01:2019/12/31[dp])`	2026-09-28	pubmed
y2020	2020-01-01 → 2020-12-31	65	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2020/01/01:2020/12/31[dp])`	2026-09-28	pubmed
y2021	2021-01-01 → 2021-12-31	57	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2021/01/01:2021/12/31[dp])`	2026-09-28	pubmed
y2022	2022-01-01 → 2022-12-31	67	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2022/01/01:2022/12/31[dp])`	2026-09-28	pubmed
y2023	2023-01-01 → 2023-12-31	53	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2023/01/01:2023/12/31[dp])`	2026-09-28	pubmed
y2024	2024-01-01 → 2024-12-31	78	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2024/01/01:2024/12/31[dp])`	2026-09-28	pubmed
y2025	2025-01-01 → 2025-12-31	60	`("Malignant Genitourinary System Neoplasm"[tiab] OR "Genitourinary Cancer"[tiab] OR "Genitourinary System Cancer"[tiab] OR "Cancer of Genitourinary System"[tiab] OR "Malignant Genitourinary Neoplasm"[tiab] OR "Cancer of the Genitourinary System"[tiab]) AND (2025/01/01:2025/12/31[dp])`	2026-09-28	pubmed

Data updated 4 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (888)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 276–300 of 888 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Letter to the Editor: ADC as a non-invasive surrogate for PD-L1 in cervical cancer-addressing potential confounding and the leap to immunotherapy selection.
Jia Jia, Liehong Wang, Fei Wang · Eur Radiol · Sep 18, 2026 · PMID 42758291 · candidate dictionary pubmed
Reply to the Letter to the Editor: ADC as a non-invasive surrogate for PD-L1 in cervical cancer-addressing potential confounding and the leap to immunotherapy selection.
Wei Yang · Eur Radiol · Sep 18, 2026 · PMID 42758286 · candidate dictionary pubmed
Is This the End of the Cisplatin Eligibility Era in Muscle-invasive Bladder Cancer? Letter in reference to: Matthew D. Galsky, Begoña P. Valderrama, Marco Maruzzo, et al. Enfortumab vedotin and pembrolizumab in cisplatin-eligible bladder cancer. N Engl J Med 2026;395:338-48. doi:10.1056/NEJMoa2601486; and Galsky MD, Hahn NM, Rosenberg J, et al. A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy. Lancet Oncol 2011;12:211-214. doi:10.1016/S1470-2045(10)70275-8.